Patent Assignment
Reel/Frame 018893/0641
Assignment of Assignor's Interest
Recorded: 2007-02-12
Pages: 5
Assignors
COWLEY, MICHAEL A.
Executed: 2007-01-16
MCKINNEY, ANTHONY A.
Executed: 2007-01-11
TOLLEFSON, GARY
Executed: 2007-01-17
Assignee
OREXIGEN THERAPEUTICS, INC.
SUITE 160, 12481 HIGH BLUFF DRIVE, SAN DIEGO, CALIFORNIA, 92130
Covered Property
(1)
Compositions and methods for increasing insulin sensitivity
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Mar 21, 2016
From: OREXIGEN THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 038180/0021 →
Assignment of Assignor's Interest
Aug 2, 2018
From: OREXIGEN THERAPEUTICS, INC.
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 046688/0661 →
Security Interest
Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Release of Security Interest
Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name
Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest
Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →